Clinical Trials Browser

Phase 1/2 × INDUSTRY × TPI-287 × Clear all

NCT01933815 2023-02-22

Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma

Phase 1/2 Suspended

Glioblastoma